Related Experiment Video
Updated: Sep 16, 2025

Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs
Published on: June 23, 2022
Cardiac alterations induced by Trypanosoma cruzi extracellular vesicles and immune complexes
Alberto Cornet-Gomez1, Francisco O'Valle2,3,4, José M Garrido2,5,6
1Department of Parasitology, Biochemical and Molecular Parasitology Group CTS-183, and Institute of Biotechnology, University of Granada, Granada, Spain.
Insights
Extracellular vesicles (EVs) from Trypanosoma cruzi, forming immune complexes with IgG, induced cardiac damage in mice, mimicking Chagas disease cardiomyopathy. These EVs are identified as potential virulence factors contributing to Chagas disease progression.
Area of Science:
- Immunology
- Parasitology
- Cardiology
Background:
- Chagas disease (CD), caused by Trypanosoma cruzi, often leads to severe cardiac complications in its chronic phase.
- The precise mechanisms driving Chagas cardiomyopathy remain incompletely understood, with proposed roles for parasite factors and host immune responses.
- Extracellular vesicles (EVs) are implicated in parasite-host communication and immune modulation, with emerging potential as diagnostic tools.
Purpose of the Study:
- To investigate the role of EVs released by Trypanosoma cruzi and their immune complexes (ICs) with anti-T. cruzi IgGs in the development of cardiac alterations.
- To assess the impact of EVs and ICs on cardiac function, protein expression, and inflammatory markers in a murine model.
Main Methods:
- Mice were intravenously injected with EVs and ICs (EVs-IgG) over 21 days.
- Evaluated autoantibody presence, electrocardiography (ECG), cardiac histopathology, and protein and cytokine expression in the heart.
- Measured serum B-type natriuretic peptide (BNP) levels.
Main Results:
- EVs and ICs induced ECG alterations, including changes in heart rate and PR interval.
- Cardiac structural changes and reduced expression of key proteins (connexin 43, tubulin, dynein) were observed.
- VCAM-1 expression was altered, cytokine profiles in the heart changed, and serum BNP levels increased, indicating cardiac damage.
Conclusions:
- EVs shed by Trypanosoma cruzi and the immune complexes they form with IgG can induce cardiac alterations similar to those in Chagas disease.
- This study underscores the significant role of EVs in Chagas disease pathogenicity.
- EVs should be considered critical virulence factors in the development and progression of Chagas disease.
Background:
Trypanosoma cruzi is a protozoan parasite responsible for American trypanosomiasis or Chagas disease (CD). This disease is characterized by the presence of cardiac or gastrointestinal symptoms in many patients during the chronic phase, with cardiac symptoms being the most common and severe, affecting approximately 30% of all patients. Although the origin of these pathologies remains unclear, several mechanisms have been proposed, involving factors related to T. cruzi and the host immune response. Extracellular vesicles (EVs) have been studied for their role in parasite-host cell communication, in modulating the host's immune response and more recently as diagnostic tools.
Methodology And Main Findings:
In this study, we describe the role of EVs released by trypomastigotes and the immune complexes (ICs) they form with anti-T. cruzi IgGs (EVs-IgG) in the development of cardiac symptoms compatible with Chagas cardiomyopathy in mice. Autoantibodies detection, electrocardiographic, histopathological, and immunological analyses in mice's hearts were performed. The studies carried out revealed that, while the inoculation of EVs and ICs (seven intravenous injections of 2 µg of EVs and ICs over 21 days) did not elicit the appearance of autoantibodies, it led to ECG alterations (heart rate and PR interval), changes in heart cavity areas and wall thickness, and reduced expression of crucial proteins for heart function (connexin 43, tubulin, and dynein), as well as VCAM-1 and altered the cytokine expression profile in the heart. Finally, both EVs-inoculated and ICs-inoculated mice showed an increased presence of B-type natriuretic peptide (BNP) in serum, suggesting that EVs or ICs may participate in the onset of cardiac damage.
Conclusions:
Our results confirm the ability of EVs shed by the infective forms of T. cruzi and the immune complexes they form with IgG to induce cardiac alterations in mice similar to those described in the literature, in T. cruzi-infected mice as well as in Chagas disease patients. This study highlights the role of EVs in the pathogenicity of Chagas disease and reinforces the importance of considering them as virulence factors in the development of Chagas disease.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy

